Emerging typhoid superbug highlights need for antibiotic stewardship

A new study revealing the rise of a multidrug-resistant typhoid strain called H58, has emphasized the need for antibiotic stewardship. » Action plan for formulary managers

Treximet gets FDA green light for pediatric migraines

FDA has approved sumatriptan and naproxen sodium (Treximet, Pernix Therapeutics) for the treatment of migraines in pediatric patients. » Recommended dosing

Continuing Education

MTM essentials for asthma management: Part 2

This month's CE activity is part of the CE series, MTM for the Patient with Respiratory Disease. From April 2015 through December 2015, pharmacists can earn up to 18 hours of CPE credit with 9 monthly knowledge-based activities from the University of Connecticut School of Pharmacy and Drug Topics.

The goal of this month's activity is to review the stepwise approach to the management of pediatric and adult asthma and the pharmacotherapies commonly used in asthma treatment.

To read and print the article with TEST questions, click here

To proceed to the online exams and earn up to 2 CPE credits, click here to log in with the Session Code: 15DT30-PYJ23.

Announcement: The login to the Online CE Center is https://web2.uconn.edu/pharmacyce/login.php. All current user registration has been uploaded for your convenience. Current users do not need to register. To review you registration page to ensure the data is up to date or to register, go to https://web2.uconn.edu/pharmacyce/program_register.php. For a full list of courses, go to http://pharmacy.uconn.edu/academics/ce/drug-topics-and-uconn-ce/

New antibacterial treatment for plague approved

FDA has approved moxifloxacin (Avelox, Bayer Healthcare) for the treatment of patients with plague. » 3 most common forms of plague

• Hospitals not doing all they can to prevent C diff infections

• First atypical antipsychotic approved for pediatric patients with bipolar I disorder in 5 years

RESOURCES

Latest Clinical News

UBM MEDICA